High biologics demand spurs need for greater contract manufacturing
Pharmaceutical Technology
APRIL 24, 2023
Having steadily risen over the last two decades, 2020 saw more approvals for biopharmaceuticals, often termed as biologics, than any other year in the last decade, according to GlobalData analysis. These attributes make some biologic drugs, especially monoclonal antibodies more specific and targeted in their treatment.
52 
Let's personalize your content